{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "14",
          "submission_status": "AP",
          "submission_status_date": "20221216",
          "submission_class_code": "REMS",
          "submission_class_code_description": "REMS"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "20",
          "submission_status": "AP",
          "submission_status_date": "20250221",
          "submission_class_code": "REMS",
          "submission_class_code_description": "REMS"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "12",
          "submission_status": "AP",
          "submission_status_date": "20221206",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "9",
          "submission_status": "AP",
          "submission_status_date": "20220503",
          "submission_class_code": "REMS",
          "submission_class_code_description": "REMS"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "15",
          "submission_status": "AP",
          "submission_status_date": "20240320",
          "submission_class_code": "REMS",
          "submission_class_code_description": "REMS"
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20180614",
          "review_priority": "STANDARD",
          "submission_class_code": "UNKNOWN",
          "application_docs": [
            {
              "id": "54627",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/205299Orig1s000ltr.pdf",
              "date": "20180620",
              "type": "Letter"
            },
            {
              "id": "76378",
              "url": "https://www.accessdata.fda.gov/scripts/cder/rems/index.cfm?event=RemsDetails.page&REMS=9",
              "date": "20231106",
              "type": "REMS"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20181031",
          "submission_class_code": "REMS",
          "submission_class_code_description": "REMS"
        }
      ],
      "application_number": "ANDA205299",
      "sponsor_name": "DR REDDYS LABS SA",
      "openfda": {
        "application_number": [
          "ANDA205299"
        ],
        "brand_name": [
          "BUPRENORPHINE AND NALOXONE"
        ],
        "generic_name": [
          "BUPRENORPHINE AND NALOXONE"
        ],
        "manufacturer_name": [
          "Dr.Reddys Laboratories Inc"
        ],
        "product_ndc": [
          "43598-579",
          "43598-582"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "BUCCAL",
          "SUBLINGUAL"
        ],
        "substance_name": [
          "BUPRENORPHINE HYDROCHLORIDE",
          "NALOXONE"
        ],
        "rxcui": [
          "1010600",
          "1010604"
        ],
        "spl_id": [
          "94051f2a-cce3-5dcf-8960-1d36168d77c0"
        ],
        "spl_set_id": [
          "718756d7-0131-b173-6c45-5ee039b311b0"
        ],
        "package_ndc": [
          "43598-579-01",
          "43598-579-30",
          "43598-582-01",
          "43598-582-30"
        ],
        "nui": [
          "N0000175691",
          "N0000000154"
        ],
        "pharm_class_epc": [
          "Opioid Antagonist [EPC]"
        ],
        "pharm_class_moa": [
          "Opioid Antagonists [MoA]"
        ],
        "unii": [
          "36B82AMQ7N",
          "56W8MW3EN1"
        ]
      },
      "products": [
        {
          "product_number": "002",
          "reference_drug": "No",
          "brand_name": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE",
          "active_ingredients": [
            {
              "name": "BUPRENORPHINE HYDROCHLORIDE",
              "strength": "EQ 8MG BASE"
            },
            {
              "name": "NALOXONE HYDROCHLORIDE",
              "strength": "EQ 2MG BASE"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "FILM",
          "route": "BUCCAL, SUBLINGUAL",
          "marketing_status": "Prescription",
          "te_code": "AB"
        },
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE",
          "active_ingredients": [
            {
              "name": "BUPRENORPHINE HYDROCHLORIDE",
              "strength": "EQ 2MG BASE"
            },
            {
              "name": "NALOXONE HYDROCHLORIDE",
              "strength": "EQ 0.5MG BASE"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "FILM",
          "route": "BUCCAL, SUBLINGUAL",
          "marketing_status": "Prescription",
          "te_code": "AB"
        }
      ]
    }
  ]
}